We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.37B
AUM Growth
+$218M
Cap. Flow
+$142M
Cap. Flow %
5.96%
Top 10 Hldgs %
34.53%
Holding
463
New
51
Increased
101
Reduced
189
Closed
15

Top Sells

Rank Stock Value
1
OMER icon
Omeros
OMER
+$7.82M
2
T icon
AT&T
T
+$6.06M
3
GIII icon
G-III Apparel Group
GIII
+$4.1M
4
RIG icon
Transocean
RIG
+$3.47M
5
PXD
Pioneer Natural Resource Co.
PXD
+$3.16M

Sector Composition

Rank Sector Weight
1 Healthcare 19.37%
2 Energy 18.91%
3 Financials 11.48%
4 Industrials 10.98%
5 Technology 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
451
Eagle Materials
EXP
$6.86B
-2,490
Closed -$261K
GIII icon
452
G-III Apparel Group
GIII
$1.55B
-92,430
Closed -$4.1M
GTN icon
453
CALL
Gray Television
GTN
$430M
-1,000
Closed -$16K
TRP icon
454
TC Energy
TRP
$70.5B
-6,607
Closed -$285K
NBL
455
DELISTED
Noble Energy, Inc.
NBL
-5,732
Closed -$202K
HCR
456
DELISTED
Hi-Crush Inc. Common Stock
HCR
-16,750
Closed -$198K
CHK
457
DELISTED
Chesapeake Energy Corporation
CHK
-1,712
Closed -$1.79M
SCG
458
DELISTED
Scana
SCG
-8,742
Closed -$337K
AAV
459
DELISTED
Advantage Oil & Gas Ltd
AAV
-38,650
Closed -$120K
PRKR
460
CALL
DELISTED
Parkervision Inc
PRKR
-40,000
Closed -$26K
PRKR
461
DELISTED
Parkervision Inc
PRKR
-314,200
Closed -$206K
NTG.RT
462
DELISTED
Tortoise MLP Fund, Inc.
NTG.RT
-20,004
Closed -$7K
GCVRZ
463
DELISTED
Sanofi Contingent Value Rights
GCVRZ
-10,000
Closed -$5K

Similar funds

Ingalls & Snyder LLC's Q3 2018 Portfolio in Review

As of Q3 2018, Ingalls & Snyder LLC held 463 positions worth $2.37B, up 10% from $2.15B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ingalls & Snyder LLC deployed $142M of net new capital in Q3 2018, opening 51 new positions and adding to 101 existing holdings. Its largest new stake was ORBCOMM, Inc.: 1,167,077 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Omeros, an estimated $7.82M trimmed.

  • Ingalls & Snyder LLC's largest Q3 2018 buy was ORBCOMM, Inc.: 1,167,077 shares worth $12.7M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q3 2018, an estimated $15.1M increase.
  • Ingalls & Snyder LLC's biggest Q3 2018 reduction was Omeros, cutting an estimated $7.82M.
  • Ingalls & Snyder LLC fully exited G-III Apparel Group in Q3 2018, selling an estimated $4.1M.
  • Ingalls & Snyder LLC's ten largest holdings make up 35% of its $2.37B portfolio in Q3 2018.
  • Ingalls & Snyder LLC opened 51 new positions and closed 15 in Q3 2018.
  • Ingalls & Snyder LLC's portfolio value rose 10% quarter-over-quarter to $2.37B.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2018, filed 24 Oct 2018.